XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.200
0.00 (0.00%)
At close: Jan 9, 2026
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 20.82 million as of January 9, 2026. Its market cap has decreased by -74.85% in one year.
Market Cap
20.82M
Enterprise Value
20.23M
Revenue
3.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 20.82M, a decrease of -97.42%. That is a compound annual growth rate of -16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 20.82M | -8.33% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.47B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.49B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 664.14M |